Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

[1]  B. Freeman,et al.  Nitro-fatty acids: New drug candidates for chronic inflammatory and fibrotic diseases. , 2018, Nitric oxide : biology and chemistry.

[2]  M. Nyegaard,et al.  Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogramming , 2018, Nature Communications.

[3]  Aikseng Ooi,et al.  A catalogue of somatic NRF2 gain-of-function mutations in cancer , 2018, Scientific Reports.

[4]  B. Freeman,et al.  Electrophilic nitroalkene-tocopherol derivatives: synthesis, physicochemical characterization and evaluation of anti-inflammatory signaling responses , 2018, Scientific Reports.

[5]  Xi Xiao,et al.  The dietary flavone luteolin epigenetically activates the Nrf2 pathway and blocks cell transformation in human colorectal cancer HCT116 cells , 2018, Journal of cellular biochemistry.

[6]  G. Hassanzadeh,et al.  The Flavone Luteolin Improves Central Nervous System Disorders by Different Mechanisms: A Review , 2018, Journal of Molecular Neuroscience.

[7]  A. Levonen,et al.  Regulation of stress signaling pathways by nitro-fatty acids. , 2018, Nitric oxide : biology and chemistry.

[8]  A. I. Rojo,et al.  Transcription factor NFE2L2/NRF2 modulates chaperone-mediated autophagy through the regulation of LAMP2A , 2018, Autophagy.

[9]  P. Giunti,et al.  Novel Nrf2-Inducer Prevents Mitochondrial Defects and Oxidative Stress in Friedreich’s Ataxia Models , 2018, Front. Cell. Neurosci..

[10]  A. I. Rojo,et al.  Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy , 2018, Redox Biology.

[11]  Donna D. Zhang,et al.  NRF2 and the Hallmarks of Cancer. , 2018, Cancer cell.

[12]  Masayuki Yamamoto,et al.  The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis. , 2018, Physiological reviews.

[13]  V. O’Donnell,et al.  The discovery of nitro-fatty acids as products of metabolic and inflammatory reactions and mediators of adaptive cell signaling. , 2018, Nitric oxide : biology and chemistry.

[14]  S. Ylä-Herttuala,et al.  Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice , 2018, Cardiovascular research.

[15]  R. de Cabo,et al.  Nrf2 Deficiency Exacerbates Obesity-Induced Oxidative Stress, Neurovascular Dysfunction, Blood–Brain Barrier Disruption, Neuroinflammation, Amyloidogenic Gene Expression, and Cognitive Decline in Mice, Mimicking the Aging Phenotype , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[16]  K. Ghoreschi,et al.  A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis , 2018, Experimental dermatology.

[17]  K. Delucchi,et al.  Identification of urinary metabolites that correlate with clinical improvements in children with autism treated with sulforaphane from broccoli , 2018, Molecular Autism.

[18]  K. Itoh,et al.  C151 in KEAP1 is the main cysteine sensor for the cyanoenone class of NRF2 activators, irrespective of molecular size or shape , 2018, Scientific Reports.

[19]  A. Bach,et al.  Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases. , 2018, Journal of medicinal chemistry.

[20]  M. Walker,et al.  KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy , 2018, Brain : a journal of neurology.

[21]  Peter A. Calabresi,et al.  Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity , 2018, Science.

[22]  R. Gold,et al.  The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis , 2018, Annals of clinical and translational neurology.

[23]  Steven J. M. Jones,et al.  Oncogenic Signaling Pathways in The Cancer Genome Atlas. , 2018, Cell.

[24]  Steven J. M. Jones,et al.  Comprehensive Characterization of Cancer Driver Genes and Mutations , 2018, Cell.

[25]  Matthew E. Ritchie,et al.  Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment. , 2018, Cell metabolism.

[26]  E. Guney,et al.  Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach , 2018, Pharmacological Reviews.

[27]  Maxim N. Artyomov,et al.  Electrophilic properties of itaconate and derivatives regulate the IκBζ–ATF3 inflammatory axis , 2018, Nature.

[28]  John Szpyt,et al.  Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1 , 2018, Nature.

[29]  Richard D Emes,et al.  Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease Is Enhanced by Nrf2 Agonists , 2018, American journal of respiratory and critical care medicine.

[30]  G. Michalopoulos,et al.  Nrf2 prevents Notch-induced insulin resistance and tumorigenesis in mice. , 2018, JCI insight.

[31]  Xiuwen Wu,et al.  The mitochondrially targeted antioxidant MitoQ protects the intestinal barrier by ameliorating mitochondrial DNA damage via the Nrf2/ARE signaling pathway , 2018, Cell Death & Disease.

[32]  D. Harrison,et al.  Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2) , 2017, Cellular and molecular gastroenterology and hepatology.

[33]  J. Hayes,et al.  Oncogene-Stimulated Congestion at the KEAP1 Stress Signaling Hub Allows Bypass of NRF2 and Induction of NRF2-Target Genes that Promote Tumor Survival. , 2017, Cancer cell.

[34]  S. Kügler,et al.  Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy , 2017, Redox biology.

[35]  Benjamin F. Cravatt,et al.  Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer , 2017, Cell.

[36]  M. V. Vander Heiden,et al.  Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer , 2017, eLife.

[37]  Francisco J. Sánchez-Rivera,et al.  Keap1 loss promotes Kras-driven lung cancer and results in a dependence on glutaminolysis , 2017, Nature Medicine.

[38]  G. Ball,et al.  Transcription factors NRF2 and HSF1 have opposing functions in autophagy , 2017, Scientific Reports.

[39]  G. Wells,et al.  Reversible Keap1 inhibitors are preferential pharmacological tools to modulate cellular mitophagy , 2017, Scientific Reports.

[40]  R. Gold,et al.  Efficacy and Tolerability of Delayed-release Dimethyl Fumarate in Black, Hispanic, and Asian Patients with Relapsing-Remitting Multiple Sclerosis: Post Hoc Integrated Analysis of DEFINE and CONFIRM , 2017, Neurology and Therapy.

[41]  T. Münzel,et al.  Redox regulation of cardiovascular inflammation – Immunomodulatory function of mitochondrial and Nox‐derived reactive oxygen and nitrogen species , 2017, Free radical biology & medicine.

[42]  R. Gold,et al.  Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM. , 2017, Clinical therapeutics.

[43]  S. Lovestone,et al.  NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology , 2017, Redox biology.

[44]  N. Habib,et al.  Non-alcoholic fatty liver disease: A sign of systemic disease. , 2017, Metabolism: clinical and experimental.

[45]  S. Friend,et al.  Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes , 2017, Science Translational Medicine.

[46]  D. Schmoll,et al.  The Keap1-Nrf2 protein-protein interaction: A suitable target for small molecules. , 2017, Drug discovery today. Technologies.

[47]  S. Hersch,et al.  KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients , 2017, Proceedings of the National Academy of Sciences.

[48]  J. Hiscott,et al.  Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral Immunity , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[49]  Takafumi Suzuki,et al.  The novel Nrf2 inducer TFM‐735 ameliorates experimental autoimmune encephalomyelitis in mice , 2017, European journal of pharmacology.

[50]  Pratap Devarapalli,et al.  Wogonin, a plant derived small molecule, exerts potent anti‐inflammatory and chondroprotective effects through the activation of ROS/ERK/Nrf2 signaling pathways in human Osteoarthritis chondrocytes , 2017, Free radical biology & medicine.

[51]  A. Tan,et al.  Brusatol overcomes chemoresistance through inhibition of protein translation , 2017, Molecular carcinogenesis.

[52]  T. Chou,et al.  Keap1/Cullin3 Modulates p62/SQSTM1 Activity via UBA Domain Ubiquitination. , 2017, Cell reports.

[53]  S. Wehage,et al.  Stabilized sulforaphane for clinical use: Phytochemical delivery efficiency , 2017, Molecular nutrition & food research.

[54]  P. Milkiewicz,et al.  Protection against oxidative stress mediated by the Nrf2/Keap1 axis is impaired in Primary Biliary Cholangitis , 2017, Scientific Reports.

[55]  Hiroki Shima,et al.  Glucocorticoid receptor signaling represses the antioxidant response by inhibiting histone acetylation mediated by the transcriptional activator NRF2 , 2017, The Journal of Biological Chemistry.

[56]  A. Dinkova-Kostova,et al.  Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants☆ , 2017, Archives of biochemistry and biophysics.

[57]  A. Levonen,et al.  Keap1 as the redox sensor of the antioxidant response. , 2017, Archives of biochemistry and biophysics.

[58]  Masayuki Yamamoto,et al.  Halofuginone enhances the chemo‐sensitivity of cancer cells by suppressing NRF2 accumulation , 2017, Free radical biology & medicine.

[59]  A. I. Rojo,et al.  Modulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseases , 2017, Redox biology.

[60]  B. Shaby,et al.  Nrf2 mitigates LRRK2- and α-synuclein–induced neurodegeneration by modulating proteostasis , 2016, Proceedings of the National Academy of Sciences.

[61]  Bolan Yu,et al.  Nuclear Factor Erythroid 2-related Factor 2 Deficiency Exacerbates Lupus Nephritis in B6/lpr mice by Regulating Th17 Cell Function , 2016, Scientific Reports.

[62]  C. Proby,et al.  Whole-Exome Sequencing Validates a Preclinical Mouse Model for the Prevention and Treatment of Cutaneous Squamous Cell Carcinoma , 2016, Cancer Prevention Research.

[63]  J. Lopes,et al.  Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosis , 2016, Redox biology.

[64]  A. Dinkova-Kostova,et al.  The multifaceted role of Nrf2 in mitochondrial function , 2016, Current opinion in toxicology.

[65]  G. Criner,et al.  Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial , 2016, PloS one.

[66]  M. Ferrer,et al.  Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors. , 2016, ACS chemical biology.

[67]  Liang Liu,et al.  S-propargyl-cysteine attenuates inflammatory response in rheumatoid arthritis by modulating the Nrf2-ARE signaling pathway , 2016, Redox biology.

[68]  Masayuki Yamamoto,et al.  Small Maf proteins (MafF, MafG, MafK): History, structure and function. , 2016, Gene.

[69]  R. Abagyan,et al.  SIRT2- and NRF2-Targeting Thiazole-Containing Compound with Therapeutic Activity in Huntington's Disease Models. , 2016, Cell chemical biology.

[70]  M. L. de Ceballos,et al.  Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes , 2016, Autophagy.

[71]  Yajing Wang,et al.  Dimethyl fumarate ameliorates dextran sulfate sodium-induced murine experimental colitis by activating Nrf2 and suppressing NLRP3 inflammasome activation. , 2016, Biochemical pharmacology.

[72]  S. Kügler,et al.  Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease. , 2016, Antioxidants & redox signaling.

[73]  L. Cai,et al.  Genetic variants of nuclear factor erythroid‐derived 2‐like 2 associated with the complications in Han descents with type 2 diabetes mellitus of Northeast China , 2016, Journal of cellular and molecular medicine.

[74]  Lin Wang,et al.  Prevention of Carcinogen-Induced Oral Cancer by Sulforaphane , 2016, Cancer Prevention Research.

[75]  Xin Wang,et al.  Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 Activation , 2016, Diabetes.

[76]  Weigang Zhang,et al.  Genetic polymorphism of the Nrf2 promoter region is associated with vitiligo risk in Han Chinese populations , 2016, Journal of cellular and molecular medicine.

[77]  A. Dinkova-Kostova,et al.  Loss of Nrf2 abrogates the protective effect of Keap1 downregulation in a preclinical model of cutaneous squamous cell carcinoma , 2016, Scientific Reports.

[78]  Q. You,et al.  An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis , 2016, Scientific Reports.

[79]  K. Nakayama,et al.  Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription , 2016, Nature Communications.

[80]  T. Shibata,et al.  NRF2 Intensifies Host Defense Systems to Prevent Lung Carcinogenesis, but After Tumor Initiation Accelerates Malignant Cell Growth. , 2016, Cancer research.

[81]  H. Moreno-Macías,et al.  Association of Nuclear Factor-Erythroid 2-Related Factor 2, Thioredoxin Interacting Protein, and Heme Oxygenase-1 Gene Polymorphisms with Diabetes and Obesity in Mexican Patients , 2016, Oxidative medicine and cellular longevity.

[82]  Navdeep S. Chandel,et al.  Fundamentals of cancer metabolism , 2016, Science Advances.

[83]  C. Barnes,et al.  Reduced Nrf2 expression mediates the decline in neural stem cell function during a critical middle‐age period , 2016, Aging cell.

[84]  H. Willems,et al.  Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery. , 2016, Journal of medicinal chemistry.

[85]  R. Nagatomi,et al.  Nrf2-Mediated Regulation of Skeletal Muscle Glycogen Metabolism , 2016, Molecular and Cellular Biology.

[86]  J. Bolaños.  Bioenergetics and redox adaptations of astrocytes to neuronal activity , 2016, Journal of neurochemistry.

[87]  Masayuki Yamamoto,et al.  Keap1/Nrf2 pathway activation leads to a repressed hepatic gluconeogenic and lipogenic program in mice on a high-fat diet. , 2016, Archives of biochemistry and biophysics.

[88]  E. Chang,et al.  Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse , 2016, Neuron.

[89]  Hongting Zheng,et al.  An Essential Role of NRF2 in Diabetic Wound Healing , 2015, Diabetes.

[90]  James Lee,et al.  Application of Mass Spectrometry Profiling to Establish Brusatol as an Inhibitor of Global Protein Synthesis , 2015, Molecular & Cellular Proteomics.

[91]  Eugenia G. Giannopoulou,et al.  Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH , 2015, Science.

[92]  Tetsuhiro Tanaka,et al.  Recent advances in understanding of chronic kidney disease , 2015, F1000Research.

[93]  Takafumi Suzuki,et al.  Characterizations of Three Major Cysteine Sensors of Keap1 in Stress Response , 2015, Molecular and Cellular Biology.

[94]  J. Hayes,et al.  Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. , 2015, Free radical biology & medicine.

[95]  Sina Hadi Sohi,et al.  BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis , 2015, Nucleic Acids Res..

[96]  R. Deberardinis,et al.  NRF2 regulates serine biosynthesis in non-small cell lung cancer , 2015, Nature Genetics.

[97]  K. Schmierer,et al.  No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine , 2015, Neurology: Neuroimmunology & Neuroinflammation.

[98]  A. Dinkova-Kostova,et al.  Pharmacokinetics and pharmacodynamics of orally administered acetylenic tricyclic bis(cyanoenone), a highly potent Nrf2 activator with a reversible covalent mode of action , 2015, Biochemical and biophysical research communications.

[99]  Geoff Wells,et al.  Design, Synthesis, and Evaluation of Triazole Derivatives That Induce Nrf2 Dependent Gene Products and Inhibit the Keap1-Nrf2 Protein-Protein Interaction. , 2015, Journal of medicinal chemistry.

[100]  P. Giunti,et al.  Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia. , 2015, Pharmacological research.

[101]  D. Ferguson,et al.  Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405 , 2015, PloS one.

[102]  P. Schultz,et al.  A Small Molecule Inhibits Deregulated NRF2 Transcriptional Activity in Cancer. , 2015, ACS chemical biology.

[103]  Q. You,et al.  Structure-Activity and Structure-Property Relationship and Exploratory in Vivo Evaluation of the Nanomolar Keap1-Nrf2 Protein-Protein Interaction Inhibitor. , 2015, Journal of medicinal chemistry.

[104]  A. K. Bauri,et al.  The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance. , 2015, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[105]  W. Bao,et al.  Association between the NF-E2 Related Factor 2 Gene Polymorphism and Oxidative Stress, Anti-Oxidative Status, and Newly-Diagnosed Type 2 Diabetes Mellitus in a Chinese Population , 2015, International journal of molecular sciences.

[106]  H. Naitow,et al.  Multiple binding modes of a small molecule to human Keap1 revealed by X-ray crystallography and molecular dynamics simulation , 2015, FEBS open bio.

[107]  N. Mottet,et al.  Effect of Sulforaphane in Men with Biochemical Recurrence after Radical Prostatectomy , 2015, Cancer Prevention Research.

[108]  J. M. Bradshaw,et al.  Prolonged and tunable residence time using reversible covalent kinase inhibitors , 2015, Nature chemical biology.

[109]  Ying Zhang,et al.  Nrf2 regulates ROS production by mitochondria and NADPH oxidase , 2015, Biochimica et biophysica acta.

[110]  S. Ibbotson,et al.  Nrf2 Activation Protects against Solar-Simulated Ultraviolet Radiation in Mice and Humans , 2015, Cancer Prevention Research.

[111]  Y. Nakagami,et al.  Novel Nrf2 activators from microbial transformation products inhibit blood–retinal barrier permeability in rabbits , 2015, British journal of pharmacology.

[112]  G. Joshi,et al.  Increased Alzheimer's disease–like pathology in the APP/ PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy , 2015, Neurobiology of Aging.

[113]  Masayuki Yamamoto,et al.  The Keap1-Nrf2 system and diabetes mellitus. , 2015, Archives of biochemistry and biophysics.

[114]  N. Vaziri,et al.  Systemic inflammation and oxidative stress in hemodialysis patients are associated with down-regulation of Nrf2 , 2015, Journal of Nephrology.

[115]  H. Zetterberg,et al.  Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson’s disease – a multicenter study , 2014, BMC Medical Genetics.

[116]  J. Pedraza-Chaverri,et al.  Nrf2 and Redox Status in Prediabetic and Diabetic Patients , 2014, International journal of molecular sciences.

[117]  A. Zimmerman,et al.  Sulforaphane treatment of autism spectrum disorder (ASD) , 2014, Proceedings of the National Academy of Sciences.

[118]  N. Žarković,et al.  Redox control of microglial function: molecular mechanisms and functional significance. , 2014, Antioxidants & redox signaling.

[119]  T. Maniatis,et al.  An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex , 2014, The Journal of Neuroscience.

[120]  勝俣 良紀.  Endogenous Prostaglandin D2 and Its Metabolites Protect the Heart Against Ischemia-Reperfusion Injury by Activating Nrf2(要約) , 2014 .

[121]  J. Kassis,et al.  Induction of Heme Oxygenase I (HMOX1) by HPP-4382: A Novel Modulator of Bach1 Activity , 2014, PloS one.

[122]  J. Hayes,et al.  Susceptibility of Nrf2-Null Mice to Steatohepatitis and Cirrhosis upon Consumption of a High-Fat Diet Is Associated with Oxidative Stress, Perturbation of the Unfolded Protein Response, and Disturbance in the Expression of Metabolic Enzymes but Not with Insulin Resistance , 2014, Molecular and Cellular Biology.

[123]  A. Muñoz,et al.  Rapid and Sustainable Detoxication of Airborne Pollutants by Broccoli Sprout Beverage: Results of a Randomized Clinical Trial in China , 2014, Cancer Prevention Research.

[124]  J. Yon,et al.  Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO , 2014, PloS one.

[125]  N. Hamajima,et al.  Polymorphism of Nrf2, an Antioxidative Gene, is Associated with Blood Pressure and Cardiovascular Mortality in Hemodialysis Patients , 2014, International journal of medical sciences.

[126]  J. Köhl,et al.  Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE. , 2014, The Journal of clinical investigation.

[127]  A. Cuadrado,et al.  Transcription Factors NRF2 and NF-κB Are Coordinated Effectors of the Rho Family, GTP-binding Protein RAC1 during Inflammation* , 2014, The Journal of Biological Chemistry.

[128]  G. Mann,et al.  Redox status in mammalian cells and stem cells during culture in vitro: Critical roles of Nrf2 and cystine transporter activity in the maintenance of redox balance , 2014, Redox biology.

[129]  K. Ward,et al.  Derivative of Bardoxolone Methyl, dh404, in an Inverse Dose-Dependent Manner Lessens Diabetes-Associated Atherosclerosis and Improves Diabetic Kidney Disease , 2014, Diabetes.

[130]  T. Nakajima,et al.  Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis , 2014, Genes & development.

[131]  E. Michelakis,et al.  The metabolic basis of pulmonary arterial hypertension. , 2014, Cell metabolism.

[132]  T. Ceska,et al.  Binding Mode and Structure–Activity Relationships around Direct Inhibitors of the Nrf2–Keap1 Complex , 2014, ChemMedChem.

[133]  J. Hayes,et al.  The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. , 2014, Trends in biochemical sciences.

[134]  I. Rahman,et al.  Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52 , 2014, Nature Communications.

[135]  D. Furst,et al.  Survival and Predictors of Mortality in Systemic Sclerosis‐Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry , 2014, Arthritis care & research.

[136]  P. Andersen,et al.  Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis , 2014, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[137]  Q. You,et al.  Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis. , 2014, Journal of medicinal chemistry.

[138]  M. Mancuso,et al.  Lack of Association between Nuclear Factor Erythroid-Derived 2-Like 2 Promoter Gene Polymorphisms and Oxidative Stress Biomarkers in Amyotrophic Lateral Sclerosis Patients , 2014, Oxidative medicine and cellular longevity.

[139]  H. Zhang,et al.  NRF2-mediated Notch pathway activation enhances hematopoietic reconstitution following myelosuppressive radiation. , 2014, The Journal of clinical investigation.

[140]  Hirotoshi Nakamura,et al.  Does hepatic oxidative stress enhance activation of nuclear factor-E2-related factor in patients with nonalcoholic steatohepatitis? , 2014, Antioxidants & redox signaling.

[141]  M. Suematsu,et al.  Endogenous Prostaglandin D2 and Its Metabolites Protect the Heart Against Ischemia–Reperfusion Injury by Activating Nrf2 , 2014, Hypertension.

[142]  Ja-Kyeong Lee,et al.  Up-down regulation of HO-1 and iNOS gene expressions by ethyl pyruvate via recruiting p300 to Nrf2 and depriving It from p65. , 2013, Free radical biology & medicine.

[143]  Ying Wang,et al.  Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice , 2013, Experimental Neurology.

[144]  P. Oteiza,et al.  Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets. , 2013, Antioxidants & redox signaling.

[145]  J. Yager,et al.  Reduced formation of depurinating estrogen-DNA adducts by sulforaphane or KEAP1 disruption in human mammary epithelial MCF-10A cells. , 2013, Carcinogenesis.

[146]  T. Pisitkun,et al.  Proteome-wide measurement of protein half-lives and translation rates in vasopressin-sensitive collecting duct cells. , 2013, Journal of the American Society of Nephrology : JASN.

[147]  X. Miao,et al.  Genetic variations in TERT‐CLPTM1L locus are associated with risk of lung cancer in chinese population , 2013, Molecular carcinogenesis.

[148]  G. Cortopassi,et al.  Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich's ataxia YG8R mouse model. , 2013, Antioxidants & redox signaling.

[149]  W. Zhou,et al.  Drug resistance associates with activation of Nrf2 in MCF‐7/DOX cells, and wogonin reverses it by down‐regulating Nrf2‐mediated cellular defense response , 2013, Molecular carcinogenesis.

[150]  A. Gomes,et al.  Nrf2 deficiency prevents reductive stress-induced hypertrophic cardiomyopathy. , 2013, Cardiovascular research.

[151]  C. Geismann,et al.  Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity , 2013, Oncogene.

[152]  T. Mizushima,et al.  Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. , 2013, Molecular cell.

[153]  William J Jusko,et al.  Moving from basic toward systems pharmacodynamic models. , 2013, Journal of pharmaceutical sciences.

[154]  Joachim Kraemer,et al.  Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism. , 2013, Bioorganic & medicinal chemistry.

[155]  Hye-Youn Cho.  Genomic Structure and Variation of Nuclear Factor (Erythroid-Derived 2)-Like 2 , 2013, Oxidative medicine and cellular longevity.

[156]  Masayuki Yamamoto,et al.  Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis. , 2013, Cancer research.

[157]  M. Yamada,et al.  Nrf2 Activators Attenuate the Progression of Nonalcoholic Steatohepatitis–Related Fibrosis in a Dietary Rat Model , 2013, Molecular Pharmacology.

[158]  Masayuki Yamamoto,et al.  Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration , 2013, Biology Open.

[159]  L. Djouhri,et al.  Nuclear Factor-erythroid 2 (NF-E2) p45-related Factor-2 (Nrf2) Modulates Dendritic Cell Immune Function through Regulation of p38 MAPK-cAMP-responsive Element Binding Protein/Activating Transcription Factor 1 Signaling* , 2013, The Journal of Biological Chemistry.

[160]  J. Hayes,et al.  RXRα inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2. , 2013, Cancer research.

[161]  S. Schreiber,et al.  Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction. , 2013, Bioorganic & medicinal chemistry letters.

[162]  E. Bertini,et al.  Frataxin Deficiency Leads to Reduced Expression and Impaired Translocation of NF-E2-Related Factor (Nrf2) in Cultured Motor Neurons , 2013, International journal of molecular sciences.

[163]  Masayuki Yamamoto,et al.  The absence of macrophage Nrf2 promotes early atherogenesis. , 2013, Cardiovascular research.

[164]  I. Arinze,et al.  Trafficking of the Transcription Factor Nrf2 to Promyelocytic Leukemia-Nuclear Bodies , 2013, The Journal of Biological Chemistry.

[165]  Yih-Ru Wu,et al.  Genetic analysis of NFE2L2 promoter variation in Taiwanese Parkinson's disease. , 2013, Parkinsonism & related disorders.

[166]  Q. Ma.  Role of nrf2 in oxidative stress and toxicity. , 2013, Annual review of pharmacology and toxicology.

[167]  N. Vaziri,et al.  Targeting the Transcription Factor Nrf2 to Ameliorate Oxidative Stress and Inflammation in Chronic Kidney Disease , 2012, Kidney international.

[168]  D. MacEwan,et al.  The high Nrf2 expression in human acute myeloid leukemia is driven by NF-κB and underlies its chemo-resistance. , 2012, Blood.

[169]  L. Gan,et al.  Astrocyte-Specific Overexpression of Nrf2 Delays Motor Pathology and Synuclein Aggregation throughout the CNS in the Alpha-Synuclein Mutant (A53T) Mouse Model , 2012, The Journal of Neuroscience.

[170]  Christopher J. Lyon,et al.  Myeloid Deletion of Nuclear Factor Erythroid 2−Related Factor 2 Increases Atherosclerosis and Liver Injury , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[171]  M. Ding,et al.  The synthetic triterpenoid, RTA405, increases glomerular filtration rate and reduces angiotensin II-induced contraction of glomerular mesangial cells , 2012, Kidney international.

[172]  M. Sporn,et al.  Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease , 2012, Pharmacological Reviews.

[173]  A. Cuadrado,et al.  Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. , 2012, Oncogene.

[174]  Takafumi Suzuki,et al.  Validation of the multiple sensor mechanism of the Keap1-Nrf2 system. , 2012, Free radical biology & medicine.

[175]  Masaaki Komatsu,et al.  Keap1 degradation by autophagy for the maintenance of redox homeostasis , 2012, Proceedings of the National Academy of Sciences.

[176]  A. Cuadrado,et al.  α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease. , 2012, Human molecular genetics.

[177]  H. Aburatani,et al.  Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. , 2012, Cancer cell.

[178]  T. Shinohara,et al.  Promoter demethylation of Keap1 gene in human diabetic cataractous lenses. , 2012, Biochemical and biophysical research communications.

[179]  P. Rada,et al.  Structural and Functional Characterization of Nrf2 Degradation by the Glycogen Synthase Kinase 3/β-TrCP Axis , 2012, Molecular and Cellular Biology.

[180]  H. Salamon,et al.  Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis , 2012, The Pharmacogenomics Journal.

[181]  Masayuki Yamamoto,et al.  Highly Potent Activation of Nrf2 by Topical Tricyclic Bis(Cyano Enone): Implications for Protection against UV Radiation during Thiopurine Therapy , 2012, Cancer Prevention Research.

[182]  J. Bliska,et al.  Synthesis, chemical reactivity as Michael acceptors, and biological potency of monocyclic cyanoenones, novel and highly potent anti-inflammatory and cytoprotective agents. , 2012, Journal of medicinal chemistry.

[183]  Alan J. Robinson,et al.  Fumarate Is Cardioprotective via Activation of the Nrf2 Antioxidant Pathway , 2012, Cell metabolism.

[184]  T. Shapiro,et al.  Protection of Humans by Plant Glucosinolates: Efficiency of Conversion of Glucosinolates to Isothiocyanates by the Gastrointestinal Microflora , 2012, Cancer Prevention Research.

[185]  Sarah Crunkhorn.  Deal watch: Abbott boosts investment in NRF2 activators for reducing oxidative stress , 2012, Nature Reviews Drug Discovery.

[186]  Patrick G. Shaw,et al.  Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles , 2012, Breast Cancer Research and Treatment.

[187]  M. Sporn,et al.  Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitis , 2011, Scientific reports.

[188]  Hongting Zheng,et al.  Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy , 2011, Diabetes.

[189]  C. Klaassen,et al.  Beneficial role of Nrf2 in regulating NADPH generation and consumption. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[190]  L. Leinwand,et al.  Cellular mechanisms of cardiomyopathy , 2011, The Journal of cell biology.

[191]  Scott E. Kern,et al.  Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis , 2011, Nature.

[192]  M. Hersberger,et al.  Nrf2 is essential for cholesterol crystal‐induced inflammasome activation and exacerbation of atherosclerosis , 2011, European journal of immunology.

[193]  Hailong Wu,et al.  Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells. , 2011, Journal of medicinal chemistry.

[194]  A. I. Rojo,et al.  Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. , 2011, Antioxidants & redox signaling.

[195]  A. Conney,et al.  Impact of Nrf2 on UVB‐induced skin inflammation/photoprotection and photoprotective effect of sulforaphane , 2011, Molecular carcinogenesis.

[196]  Xiuwen Tang,et al.  Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs. , 2011, Free radical biology & medicine.

[197]  G. Pahlke,et al.  Coffee constituents as modulators of Nrf2 nuclear translocation and ARE (EpRE)-dependent gene expression. , 2011, The Journal of nutritional biochemistry.

[198]  M. Selbach,et al.  Global quantification of mammalian gene expression control , 2011, Nature.

[199]  L. Yarmus,et al.  Targeting Nrf2 Signaling Improves Bacterial Clearance by Alveolar Macrophages in Patients with COPD and in a Mouse Model , 2011, Science Translational Medicine.

[200]  K. Itoh,et al.  Nrf2 degron‐fused reporter system: a new tool for specific evaluation of Nrf2 inducers , 2011, Genes to cells : devoted to molecular & cellular mechanisms.

[201]  W. Brück,et al.  Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. , 2011, Brain : a journal of neurology.

[202]  C. Carlberg,et al.  Electrophilic Nitro-fatty Acids Activate NRF2 by a KEAP1 Cysteine 151-independent Mechanism* , 2011, The Journal of Biological Chemistry.

[203]  M. Sporn,et al.  New Synthetic Triterpenoids: Potent Agents for Prevention and Treatment of Tissue Injury Caused by Inflammatory and Oxidative Stress , 2011, Journal of natural products.

[204]  R. Gold,et al.  Efficacy of Fumaric Acid Esters in the R6/2 and YAC128 Models of Huntington's Disease , 2011, PloS one.

[205]  P. Rada,et al.  SCF/β-TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner , 2011, Molecular and Cellular Biology.

[206]  Donna D. Zhang,et al.  Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism , 2011, Proceedings of the National Academy of Sciences.

[207]  J. Bryan,et al.  Conserved Intramolecular Disulfide Bond Is Critical to Trafficking and Fate of ATP-binding Cassette (ABC) Transporters ABCB6 and Sulfonylurea Receptor 1 (SUR1)/ABCC8* , 2011, The Journal of Biological Chemistry.

[208]  A. Lusis,et al.  NF-E2–Related Factor 2 Promotes Atherosclerosis by Effects on Plasma Lipoproteins and Cholesterol Transport That Overshadow Antioxidant Protection , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[209]  P. Brookes,et al.  The coordinated increased expression of biliverdin reductase and heme oxygenase‐2 promotes cardiomyocyte survival: a reductase‐based peptide counters β‐adrenergic receptor ligand‐mediated cardiac dysfunction , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[210]  Vivek T. Natarajan,et al.  Transcriptional upregulation of Nrf2-dependent phase II detoxification genes in the involved epidermis of vitiligo vulgaris. , 2010, The Journal of investigative dermatology.

[211]  C. Ahn,et al.  Suppression of NF-kappaB signaling by KEAP1 regulation of IKKbeta activity through autophagic degradation and inhibition of phosphorylation. , 2010, Cellular signalling.

[212]  M. McMahon,et al.  Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals , 2010, Proceedings of the National Academy of Sciences.

[213]  M. Sporn,et al.  Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease. , 2010, Free radical biology & medicine.

[214]  M. Kwak,et al.  Regulation of Notch1 Signaling by Nrf2: Implications for Tissue Regeneration , 2010, Science Signaling.

[215]  S. Jha,et al.  Genetic and Pharmacologic Hydrogen Sulfide Therapy Attenuates Ischemia-Induced Heart Failure in Mice , 2010, Circulation.

[216]  Liang-Che Chang,et al.  Functional Haplotypes in the Promoter Region of Transcription Factor Nrf2 in Chronic Obstructive Pulmonary Disease , 2010, Disease markers.

[217]  M. McMahon,et al.  p62/SQSTM1 Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene Transcription* , 2010, The Journal of Biological Chemistry.

[218]  T. Mariani,et al.  Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation. , 2010, American journal of respiratory cell and molecular biology.

[219]  E. White,et al.  A Noncanonical Mechanism of Nrf2 Activation by Autophagy Deficiency: Direct Interaction between Keap1 and p62 , 2010, Molecular and Cellular Biology.

[220]  Takafumi Suzuki,et al.  Genetic Analysis of Cytoprotective Functions Supported by Graded Expression of Keap1 , 2010, Molecular and Cellular Biology.

[221]  DelindaA . Johnson,et al.  The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[222]  A. M. Martín-Moreno,et al.  Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease , 2010, Glia.

[223]  D. Howells,et al.  Can Animal Models of Disease Reliably Inform Human Studies? , 2010, PLoS medicine.

[224]  Mihee M. Kim,et al.  The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1 , 2010, Nature Cell Biology.

[225]  K. Blennow,et al.  Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract , 2010, Mechanisms of Ageing and Development.

[226]  I. Hyodo,et al.  Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[227]  R. Haller,et al.  Posttranslational stability of the heme biosynthetic enzyme ferrochelatase is dependent on iron availability and intact iron-sulfur cluster assembly machinery. , 2010, Blood.

[228]  T. Ogura,et al.  Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains , 2010, Proceedings of the National Academy of Sciences.

[229]  Yi-feng Lin,et al.  The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy , 2010, Diabetes.

[230]  J. Hayes,et al.  Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. , 2010, Free radical biology & medicine.

[231]  B. Foster,et al.  Nrf2 Expression Is Regulated by Epigenetic Mechanisms in Prostate Cancer of TRAMP Mice , 2010, PloS one.

[232]  J. S. Janicki,et al.  Nrf2 Protects Against Maladaptive Cardiac Responses to Hemodynamic Stress , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[233]  M. Hung,et al.  KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta. , 2009, Molecular cell.

[234]  Richard W Orrell,et al.  Antioxidants and other pharmacological treatments for Friedreich ataxia. , 2009, The Cochrane database of systematic reviews.

[235]  Guowang Xu,et al.  Systems Biology Guided by Chinese Medicine Reveals New Markers for Sub-Typing Rheumatoid Arthritis Patients , 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[236]  H. Tanila,et al.  Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease , 2009, Proceedings of the National Academy of Sciences.

[237]  M. McMahon,et al.  Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds. , 2009, Carcinogenesis.

[238]  A. Mesecar,et al.  Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1. , 2009, The Biochemical journal.

[239]  H. Schipper,et al.  Heme oxygenase‐1 and neurodegeneration: expanding frontiers of engagement , 2009, Journal of neurochemistry.

[240]  M. Sporn,et al.  Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. , 2009, Carcinogenesis.

[241]  A. Cuadrado,et al.  Role of microglial redox balance in modulation of neuroinflammation , 2009, Current opinion in neurology.

[242]  S. Snyder,et al.  Bilirubin and glutathione have complementary antioxidant and cytoprotective roles , 2009, Proceedings of the National Academy of Sciences.

[243]  Shyam Biswal,et al.  Cigarette smoke-induced emphysema in A/J mice is associated with pulmonary oxidative stress, apoptosis of lung cells, and global alterations in gene expression. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[244]  Donna D. Zhang,et al.  Acetylation of Nrf2 by p300/CBP Augments Promoter-Specific DNA Binding of Nrf2 during the Antioxidant Response , 2009, Molecular and Cellular Biology.

[245]  A. Saxon,et al.  Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway. , 2009, Clinical immunology.

[246]  A. Cuadrado,et al.  The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease , 2009 .

[247]  Y. Kan,et al.  Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte , 2009, Proceedings of the National Academy of Sciences.

[248]  C. Ruppert,et al.  Alveolar oxidative stress is associated with elevated levels of nonenzymatic low-molecular-weight antioxidants in patients with different forms of chronic fibrosing interstitial lung diseases. , 2009, Antioxidants & redox signaling.

[249]  P. Rustin,et al.  Impaired Nuclear Nrf2 Translocation Undermines the Oxidative Stress Response in Friedreich Ataxia , 2009, PloS one.

[250]  M. P. Cole,et al.  Nitro-fatty Acid Metabolome: Saturation, Desaturation, β-Oxidation, and Protein Adduction* , 2009, Journal of Biological Chemistry.

[251]  M. Sporn,et al.  Targeting Nrf2 with the triterpenoid CDDO- imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice , 2009, Proceedings of the National Academy of Sciences.

[252]  DelindaA . Johnson,et al.  Nrf2 Activation in Astrocytes Protects against Neurodegeneration in Mouse Models of Familial Amyotrophic Lateral Sclerosis , 2008, The Journal of Neuroscience.

[253]  Cui-ping Guan,et al.  The susceptibility to vitiligo is associated with NF‐E2‐related factor2 (Nrf2) gene polymorphisms: a study on Chinese Han population , 2008, Experimental dermatology.

[254]  S. Biswal,et al.  Disruption of Nrf2, a Key Inducer of Antioxidant Defenses, Attenuates ApoE-Mediated Atherosclerosis in Mice , 2008, PloS one.

[255]  Masayuki Yamamoto,et al.  The Antioxidant Defense System Keap1-Nrf2 Comprises a Multiple Sensing Mechanism for Responding to a Wide Range of Chemical Compounds , 2008, Molecular and Cellular Biology.

[256]  A. Kong,et al.  Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. , 2008, Biochemical pharmacology.

[257]  M. L. de Ceballos,et al.  The Transcription Factor Nrf2 Is a Therapeutic Target against Brain Inflammation1 , 2008, The Journal of Immunology.

[258]  B. Crestani,et al.  Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema , 2008, Thorax.

[259]  R. Geffers,et al.  Nuclear factor-eythroid 2-related factor 2 prevents alcohol-induced fulminant liver injury. , 2008, Gastroenterology.

[260]  T. Tahara,et al.  Nrf2 gene promoter polymorphism is associated with ulcerative colitis in a Japanese population. , 2008, Hepato-gastroenterology.

[261]  T. Tahara,et al.  Nrf2 gene promoter polymorphism and gastric carcinogenesis. , 2008, Hepato-gastroenterology.

[262]  A. Cuervo,et al.  Early cellular changes after blockage of chaperone-mediated autophagy , 2008, Autophagy.

[263]  D. Liebler,et al.  Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3. , 2008, Chemical research in toxicology.

[264]  C. Wolf,et al.  Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha , 2007, Proceedings of the National Academy of Sciences.

[265]  B. Freeman,et al.  Nitro-fatty Acid Reaction with Glutathione and Cysteine , 2007, Journal of Biological Chemistry.

[266]  S. Yokoyama,et al.  Different Electrostatic Potentials Define ETGE and DLG Motifs as Hinge and Latch in Oxidative Stress Response , 2007, Molecular and Cellular Biology.

[267]  Masaki Tanito,et al.  Upregulation of thioredoxin system via Nrf2-antioxidant responsive element pathway in adaptive-retinal neuroprotection in vivo and in vitro. , 2007, Free radical biology & medicine.

[268]  J. Manautou,et al.  Emerging Role of Nrf2 in Protecting Against Hepatic and Gastrointestinal Disease , 2007, Toxicologic pathology.

[269]  A. Kong,et al.  Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. , 2006, Cancer research.

[270]  K. Marder,et al.  Frequency of LRRK2 mutations in early- and late-onset Parkinson disease , 2006, Neurology.

[271]  B. Freeman,et al.  Reversible Post-translational Modification of Proteins by Nitrated Fatty Acids in Vivo* , 2006, Journal of Biological Chemistry.

[272]  M. Kwak,et al.  Induction of 26S proteasome subunit PSMB5 by the bifunctional inducer 3-methylcholanthrene through the Nrf2-ARE, but not the AhR/Arnt-XRE, pathway. , 2006, Biochemical and biophysical research communications.

[273]  Q. Ma,et al.  Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2. , 2006, The American journal of pathology.

[274]  K. Mihara,et al.  Ubiquitin-proteasome-dependent degradation of mammalian ER stearoyl-CoA desaturase , 2006, Journal of Cell Science.

[275]  Masayuki Yamamoto,et al.  Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. , 2006, The Journal of clinical investigation.

[276]  Tsutomu Ohta,et al.  Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. , 2006, Molecular cell.

[277]  H. Aburatani,et al.  Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. , 2006, Biochemical and biophysical research communications.

[278]  G. Bjørkøy,et al.  p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death , 2005, The Journal of cell biology.

[279]  C. Bottoms,et al.  Conserved solvent and side-chain interactions in the 1.35 Angstrom structure of the Kelch domain of Keap1. , 2005, Acta crystallographica. Section D, Biological crystallography.

[280]  P. Webb.  Faculty Opinions recommendation of Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression. , 2005 .

[281]  M. Sporn,et al.  Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: implications for a molecular mechanism of action. , 2005, Bioorganic & medicinal chemistry letters.

[282]  D. Choi,et al.  Glucocorticoid Receptor (GR)-Associated SMRT Binding to C/EBPβ TAD and Nrf2 Neh4/5: Role of SMRT Recruited to GR in GSTA2 Gene Repression , 2005, Molecular and Cellular Biology.

[283]  Paul Talalay,et al.  Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[284]  Ken Itoh,et al.  Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome. , 2005, Archives of biochemistry and biophysics.

[285]  Mark Hannink,et al.  Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex , 2004, Molecular and Cellular Biology.

[286]  S. Biswal,et al.  Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. , 2004, The Journal of clinical investigation.

[287]  J. Bol,et al.  Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra , 2004, Neurobiology of Aging.

[288]  J. Harper,et al.  The Keap1-BTB Protein Is an Adaptor That Bridges Nrf2 to a Cul3-Based E3 Ligase: Oxidative Stress Sensing by a Cul3-Keap1 Ligase , 2004, Molecular and Cellular Biology.

[289]  Masayuki Yamamoto,et al.  Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2 , 2004, Molecular and Cellular Biology.

[290]  Ken Itoh,et al.  Redox-regulated Turnover of Nrf2 Is Determined by at Least Two Separate Protein Domains, the Redox-sensitive Neh2 Degron and the Redox-insensitive Neh6 Degron* , 2004, Journal of Biological Chemistry.

[291]  T. Hagen,et al.  Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[292]  M. Kwak,et al.  Antioxidants Enhance Mammalian Proteasome Expression through the Keap1-Nrf2 Signaling Pathway , 2003, Molecular and Cellular Biology.

[293]  Mark Hannink,et al.  Distinct Cysteine Residues in Keap1 Are Required for Keap1-Dependent Ubiquitination of Nrf2 and for Stabilization of Nrf2 by Chemopreventive Agents and Oxidative Stress , 2003, Molecular and Cellular Biology.

[294]  Randal J. Kaufman,et al.  Nrf2 Is a Direct PERK Substrate and Effector of PERK-Dependent Cell Survival , 2003, Molecular and Cellular Biology.

[295]  T. Murphy,et al.  Coordinate Regulation of Glutathione Biosynthesis and Release by Nrf2-Expressing Glia Potently Protects Neurons from Oxidative Stress , 2003, The Journal of Neuroscience.

[296]  Y. Kan,et al.  Identification of the NF-E2-related Factor-2-dependent Genes Conferring Protection against Oxidative Stress in Primary Cortical Astrocytes Using Oligonucleotide Microarray Analysis* , 2003, The Journal of Biological Chemistry.

[297]  D. Harrison,et al.  Role of oxidative stress in atherosclerosis. , 2003, The American journal of cardiology.

[298]  S. Biswal,et al.  Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. , 2002, Cancer research.

[299]  S. Ōmura,et al.  Accelerated degradation of mislocalized UDP-glucuronosyltransferase family 1 (UGT1) proteins in Gunn rat hepatocytes. , 2002, Archives of biochemistry and biophysics.

[300]  R. Cole,et al.  Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[301]  S. Werner,et al.  Nrf2 Transcription Factor, a Novel Target of Keratinocyte Growth Factor Action Which Regulates Gene Expression and Inflammation in the Healing Skin Wound , 2002, Molecular and Cellular Biology.

[302]  J. Quiles,et al.  Curcuma longa Extract Supplementation Reduces Oxidative Stress and Attenuates Aortic Fatty Streak Development in Rabbits , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[303]  C. Wolf,et al.  The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. , 2001, Cancer research.

[304]  M. Sporn,et al.  Synthetic oleanane and ursane triterpenoids with modified rings A and C: a series of highly active inhibitors of nitric oxide production in mouse macrophages. , 2000, Journal of medicinal chemistry.

[305]  A. Choi,et al.  Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and Nrf2 transcription factor. , 2000, The Journal of biological chemistry.

[306]  T. Shapiro,et al.  Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[307]  Altmeyer,et al.  Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study , 1998, The British journal of dermatology.

[308]  J. Fahey,et al.  Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[309]  K. Itoh,et al.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. , 1997, Biochemical and biophysical research communications.

[310]  Y. Kan,et al.  NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[311]  Y. Kan,et al.  Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[312]  Varun Garg,et al.  Comparison of four basic models of indirect pharmacodynamic responses , 1993, Journal of Pharmacokinetics and Biopharmaceutics.

[313]  H. Bonkovsky,et al.  Molecular basis for heme-dependent induction of heme oxygenase in primary cultures of chick embryo hepatocytes. Demonstration of acquired refractoriness to heme. , 1993, European journal of biochemistry.

[314]  G. Perdew,et al.  Half-life of aryl hydrocarbon receptor in Hepa 1 cells: evidence for ligand-dependent alterations in cytosolic receptor levels. , 1993, Archives of biochemistry and biophysics.

[315]  C. Cho,et al.  A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[316]  S. R. Spencer,et al.  Induction of glutathione transferases and NAD(P)H:quinone reductase by fumaric acid derivatives in rodent cells and tissues. , 1990, Cancer research.

[317]  P. Talalay,et al.  Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[318]  S. R. Majeed,et al.  Biochemistry and Molecular Cell Biology of Diabetic Complications , 2020 .

[319]  Dean P. Jones,et al.  Oxidative Stress. , 2017, Annual review of biochemistry.

[320]  S. Kügler,et al.  Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis. , 2014, Brain : a journal of neurology.

[321]  D. Choi,et al.  Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases. , 2014, Natural product reports.

[322]  D. Sin,et al.  Oxidative stress in chronic obstructive pulmonary disease: a lung and systemic process. , 2013, Canadian respiratory journal.

[323]  A. Muñoz,et al.  Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China. , 2012, Carcinogenesis.

[324]  D. Ferrington,et al.  Immunoproteasomes: structure, function, and antigen presentation. , 2012, Progress in molecular biology and translational science.

[325]  T. Kensler,et al.  Nrf2: friend or foe for chemoprevention? , 2010, Carcinogenesis.

[326]  T. Tahara,et al.  The relationship between Helicobacter pylori infection and promoter polymorphism of the Nrf2 gene in chronic gastritis. , 2007, International journal of molecular medicine.

[327]  J. Pincemail,et al.  [Oxidative stress]. , 2007, Revue medicale de Liege.

[328]  M. Grigorov,et al.  A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin a carcinogenicity in rat. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[329]  J. D. Engel,et al.  Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. , 1999, Genes & development.

[330]  K. Blennow,et al.  Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease , 2010, BMC Medical Genetics.

[331]  M. Brownlee.  Insight Review Articles , 2022 .

[332]  Y. Hayashizaki,et al.  Analysis of the human monocyte-derived macrophage transcriptome and response to lipopolysaccharide provides new insights into genetic aetiology of inflammatory bowel disease , 2017, PLoS genetics.